Acuitas Investments’s BlueLinx BXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-57,633
Closed -$5.52M 37
2021
Q4
$5.52M Buy
57,633
+9,532
+20% +$645K 2.35% 7
2021
Q3
$2.35M Buy
48,101
+20,322
+73% +$1.02M 1.03% 50
2021
Q2
$1.4M Sell
27,779
-28,555
-51% -$1.4M 0.7% 61
2021
Q1
$2.21M Sell
56,334
-43,663
-44% -$1.7M 1.27% 38
2020
Q4
$2.93M Sell
99,997
-35,697
-26% -$913K 1.9% 18
2020
Q3
$2.92M Sell
135,694
-64,344
-32% -$1.04M 2.05% 16
2020
Q2
$1.71M Buy
+200,038
New +$1.24M 2.15% 22

Other funds holding BXC

Acuitas Investments's BXC Position: Q1 2022 in Review

Acuitas Investments sold out of BlueLinx (BXC) in Q1 2022, closing a stake of 57,633 shares — an estimated $5.52M sold.

Acuitas Investments first reported a position in BXC in Q2 2020 and held it in 7 quarters. The position peaked at $5.52M in Q4 2021. 163 funds tracked by Wall St. Rank hold BXC as of Q1 2022.

  • Acuitas Investments reported no remaining BlueLinx position as of Q1 2022 after selling out during the quarter.
  • Acuitas Investments sold 57,633 BlueLinx shares in Q1 2022, an estimated $5.52M.
  • Acuitas Investments first reported a position in BlueLinx in Q2 2020 and held it in 7 quarters.
  • Acuitas Investments's BlueLinx position peaked at $5.52M in Q4 2021.
  • 163 funds tracked by Wall St. Rank held BlueLinx as of Q1 2022.

Based on Acuitas Investments's 13F filing for Q1 2022, filed 6 May 2022.